Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Radiother Oncol. 2014 Jul 1;112(3):418–424. doi: 10.1016/j.radonc.2014.05.011

Table 1.

Summary of the model parameter values for the targets and organs-at-risk involved in the investigated cancer type. D50 is the 50% response dose, γ is the maximum normalized value of the dose-response gradient and s is the relative seriality, which characterizes the volume dependence of the organ.

Structure D50 (Gy) γ s α/β Endpoint
Target Volume 41.7 2.2 10.0 control
Rectum 80.0 2.2 0.7 3.0 necrosis, stenosis
Bladder 80.0 3.0 0.18 3.0 symptomatic contracture
Small intestine 53.6 2.3 1.5 3.0 obstruction perforation
Femur 65.0 2.7 1.0 3.0 necrosis